140 related articles for article (PubMed ID: 18275774)
21. Osteoporosis drugs and jaw problems. Weighing your risks.
Mayo Clin Health Lett; 2006 Dec; 24(12):6. PubMed ID: 17304694
[No Abstract] [Full Text] [Related]
22. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases.
Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C
J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949
[No Abstract] [Full Text] [Related]
23. Osteonecrosis of the jaw after zoledronic acid and denosumab treatment.
Fusco V; Galassi C; Berruti A; Ciuffreda L; Ortega C; Ciccone G; Angeli A; Bertetto O
J Clin Oncol; 2011 Jun; 29(17):e521-2; author reply e523-4. PubMed ID: 21537047
[No Abstract] [Full Text] [Related]
24. Bone regeneration without bone grafting after resection of a segment of the mandible to treat bisphosphonate-related osteonecrosis of the jaw.
Wilde F; Hendricks J; Riese C; Pausch NC; Schramm A; Heufelder M
J Oral Maxillofac Surg; 2011 Oct; 69(10):2657-62. PubMed ID: 21741741
[No Abstract] [Full Text] [Related]
25. Bisphosphonate-associated osteonecrosis of the jaw: a six-year history of a case.
Hewson ID
N Z Dent J; 2011 Sep; 107(3):97-100. PubMed ID: 21957837
[TBL] [Abstract][Full Text] [Related]
26. Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment.
Migliorati CA; Siegel MA; Elting LS
Lancet Oncol; 2006 Jun; 7(6):508-14. PubMed ID: 16750501
[TBL] [Abstract][Full Text] [Related]
27. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
[TBL] [Abstract][Full Text] [Related]
28. Bisphosphonate-induced osteonecrosis of the jaws.
Throndson RR; Healy SM; Zwickey MR
Tex Dent J; 2005 Sep; 122(9):960-5. PubMed ID: 16320503
[No Abstract] [Full Text] [Related]
29. [Osteonecrosis of the jaw].
Pierrot-Deseilligny Despujol C; Pouchot J
Rev Med Interne; 2009 Aug; 30(8):706-7. PubMed ID: 19482388
[No Abstract] [Full Text] [Related]
30. Bisphosphonates, dental care and osteonecrosis of the jaws.
Sitters MA; Caldwell CS
Tex Dent J; 2005 Sep; 122(9):968-72. PubMed ID: 16320504
[No Abstract] [Full Text] [Related]
31. [Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer].
Amrani Raissouni T; Moya Espinosa P; Ramos Moreno E; Martínez Del Valle Torres MD; Sanz Viedma S; Ortega Lozano SJ
Rev Esp Med Nucl; 2011; 30(5):322-3. PubMed ID: 21440957
[No Abstract] [Full Text] [Related]
32. Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Fitzpatrick SG; Stavropoulos MF; Bowers LM; Neuman AN; Hinkson DW; Green JG; Bhattacharyya I; Cohen DM
J Oral Maxillofac Surg; 2012 Feb; 70(2):325-30. PubMed ID: 21723015
[No Abstract] [Full Text] [Related]
33. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
Hay KD; Bishop PA
N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
[TBL] [Abstract][Full Text] [Related]
34. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.
Olson KB; Hellie CM; Pienta KJ
Urology; 2005 Sep; 66(3):658. PubMed ID: 16140106
[TBL] [Abstract][Full Text] [Related]
35. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.
Tirelli G; Biasotto M; Chiandussi S; Dore F; De Nardi E; Di Lenarda R
Head Neck; 2009 Sep; 31(9):1249-54. PubMed ID: 19260132
[TBL] [Abstract][Full Text] [Related]
36. Zoledronic acid induced osteonecrosis of tibia and femur.
Gupta S; Jain P; Kumar P; Parikh PM
Indian J Cancer; 2009; 46(3):249-50. PubMed ID: 19574685
[No Abstract] [Full Text] [Related]
37. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
Bozas G; Roy A; Ramasamy V; Maraveyas A
Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonates: case report of nonsurgical periodontal therapy and osteochemonecrosis.
Braun E; Iacono VJ
Int J Periodontics Restorative Dent; 2006 Aug; 26(4):315-9. PubMed ID: 16939012
[TBL] [Abstract][Full Text] [Related]
39. [Osteonecrosis of the jawbone as a side effect of intravenous treatment with bisphosphonates].
Schortinghuis J; Witjes MJ; Spijkervet KL; de Visscher JG
Ned Tijdschr Geneeskd; 2007 Feb; 151(5):314-8. PubMed ID: 17326477
[TBL] [Abstract][Full Text] [Related]
40. Osteonecrosis of the jaws induced by drugs other than bisphosphonates - a call to update terminology in light of new data.
Yarom N; Elad S; Madrid C; Migliorati CA
Oral Oncol; 2010 Jan; 46(1):e1. PubMed ID: 19932046
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
